Therapy for Depressed Elders With Thought Problems

Sponsor
University of Washington (Other)
Overall Status
Completed
CT.gov ID
NCT00052091
Collaborator
National Institute of Mental Health (NIMH) (NIH)
221
2
2
66
110.5
1.7

Study Details

Study Description

Brief Summary

This study will compare the effectiveness of Problem Solving Therapy and Brief Supportive Therapy in treating elderly patients with major depression and thought problems.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Problem Solving Therapy
  • Behavioral: Brief Supportive Therapy
Phase 3

Detailed Description

Patients who suffer from a combination of major depression and executive dysfunction symptoms often respond poorly to treatment with antidepressants. It is important, therefore, to find effective alternative therapies to treat these symptoms.

Patients are randomly assigned to receive 12 sessions (1 session/week for 12 weeks) of either PST or BST. Following treatment, patients are followed for 6 months to determine functional and clinical outcomes. Depression scales, disability scales, and scales that measure problem solving skills are used to assess patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
221 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
PST in Geriatric Depression With Executive Dysfunction
Study Start Date :
Sep 1, 2002
Actual Primary Completion Date :
Mar 1, 2008
Actual Study Completion Date :
Mar 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1 Problem Solving Therapy

12 weekly sessions of problem solving therapy (PST)

Behavioral: Problem Solving Therapy
A 12 week cognitive behavioral intervention for depression that teaches patients a structured approach to solving social problems.

Experimental: 2 Brief Supportive Therapy

12 weekly sessions of brief supportive therapy (BST)

Behavioral: Brief Supportive Therapy
A 12 week intervention for depression that focuses on supporting patients attempts to cope with depression.

Outcome Measures

Primary Outcome Measures

  1. Hamilton Rating Scale for Depression [Measured at screening, weeks 1 through 12, and week 36]

Eligibility Criteria

Criteria

Ages Eligible for Study:
60 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Nonpsychotic, unipolar major depression

  • Cognitive impairment

  • English speaking

Exclusion Criteria:
  • High suicide risk

  • Dementia

  • Acute or severe medical illness

  • Current psychotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California at San Francisco San Francisco California United States 94143
2 Weill Medical College of Cornell University White Plains New York United States 10605

Sponsors and Collaborators

  • University of Washington
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Patricia A. Arean, PhD, University of California at San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Pat Arean, Professor, Psychiatry and Behavioral Sciences, University of Washington
ClinicalTrials.gov Identifier:
NCT00052091
Other Study ID Numbers:
  • H7472-19384-8
  • R01MH063982
  • DATR A4-GPS
First Posted:
Jan 23, 2003
Last Update Posted:
Jan 29, 2018
Last Verified:
Jan 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Keywords provided by Pat Arean, Professor, Psychiatry and Behavioral Sciences, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 29, 2018